- Product Partners
- Supplements Facts
- Scientific References
- Client Reviews
Pure and Potent Fish Oil... and #1 in Freshness!
If you ask your doctor to name just one supplement you should take…chances are he or she will say a fish oil rich in the omega-3s EPA and DHA.
In fact, the two most important organs in your body…your heart and brain… simply can’t function normally when you are deficient in these two omega-3s.
And studies have shown that EPA and DHA help most other parts of your body such as your vision, joint health, bone density, weight management, skin and your hair.
But not any fish oil will do. Here are three characteristics you should seek in a fish oil supplement:
1) Rich in the key omega-3s, EPA and DHA, and from a sustainable fishery.
2) Carefully filtered to remove heavy metals, pollutants and other impurities.
3) Precautionary steps to ensure the oil stays “fresh”, and does not oxidize and lose nutritional value.
NatureCity® was careful to address each of these in TrueOmega-3™.
Each serving of TrueOmega-3™ provides 818mg of EPA and DHA in two easy-to-swallow soft gels.
Since you likely get around 50mg to 100mg of EPA and DHA daily from food, TrueOmega-3™ helps you reach the 850mg level typically consumed by heart healthy cultures such as the Japanese.
In addition, the fish oil is 100% sourced from Wild Alaska Pollock (cod family) from the Alaska’s cold, clear Bering Sea, considered one of the best-managed and sustainable fisheries in the world.
After the fish oil is extracted, it goes through a molecular distillation filtration to remove PCBs, dioxins, chlorinated organic pollutants, and toxic heavy metals. This ensures the fish oil exceeds industry standards of purity.
Finally, the fish oil in TrueOmega-3™ is considered “#1 in Freshness” because of extremely low Total Oxidation (TOTOX) and Peroxide Value (PV) values. In addition to protecting against oxidation risk, these industry leading values produce a fish oil with high sensory characteristics (deodorized, no burping).
Plus, the fish oil, from harvesting in Alaska to refining in Ohio, is 100% “Made in the USA”.
AlaskOmega® – #1 in Freshness, From Sustainable Bering Sea Fishery
Overfishing of the oceans is something we all should be mindful of, which is why when seeking a fish oil supplement you should make sure it’s from a sustainable source, that is also pure, potent and fresh.
The fish oil from AlaskOmega® passes all of these tests with flying colors.
AlaskOmega® fish oil comes from Wild Alaska Pollock (codfish family) caught in Alaska’s cool, cold Bering Sea. The Alaska Pollock fishery is considered one of the best managed fisheries of the world - thanks to a holistic approach developed over 40 years.
For example, a recent assessment of the annual catch of Pollock Biomass found that just 15% of all Pollock Biomass was caught during the year, keeping the fishery healthy robust and growing. In fact, in the following year, it was found that Alaskan Pollock Biomass had increased by an impressive 65%.
What’s more, Alaskan Pollock are caught with mid water, pelagic trawls, NOT destructive demersal bottom trawls that can harm marine natural resources. This also results in less than 1% bycatch of non-target species.
Reflecting these practices, AlaskOmega® fish oil is certified as sustainable by the Marine Stewardship Council (MSC), considered by many to be the gold standard of sustainability certification. The MSC certification also covers Chain of Custody and Traceability.
Alaskan Pollock are typically 12 to 20 inches in length and ½ to 2 pounds in weight. Using small fish is a great starting point because they don’t have nearly the toxin buildup of larger more fatty larger fish like salmon or tuna.
However, even in pristine Alaskan waters, fish can still contain contaminants. So once the fish are caught and the oil is extracted, AlaskOmega® fish oils go through special “molecular distillation” purification and filtration process to remove any toxic heavy metals, PCB’s, dioxins or other impurities. This process takes place in the company’s NSF-Certified GMP facility.
This results in a premium quality fish oil that exceeds all quality standards set by health authorities worldwide. This includes being well within the standards set by GOED (Global Organization for EPA and DHA), whose standards are more strict than any single regulator in the world (including USP).
On top of this, AlaskOmega® has a market leading position for oil freshness.
Oxidation of fish oil is an important issue that is not discussed nearly enough. This occurs when three main culprits – light, oxygen and metal ions – cause fish oil to degrade and become rancid.
Not only does this affect the taste and smell of the fish oil, but also oxidation causes something much worse. It causes breaks in the structure of the omega-3 fatty acids.
The EPA and DHA literally crumble and lose their nutritional value. So you don’t get the benefits of taking these wonderful nutrients.
To ensure you get the “freshest” product possible, extra steps are taken with AlaskOmega® to prevent oxidation.
It all starts immediately after the fish is caught. Within one to two hours, the oil is cold extracted from the fish. After that, protective actions are taken to ensure the fish is minimally exposed to light, heat and oxygen.
This includes the purification process, which takes place under inert gas to further prevent oxidation and ensure the utmost freshness and quality.
During purification, compounds that make the fish oil more prone to oxidation, such as “aldehydes”, are removed. In addition, deodorization removes fishy odor and taste, and provides excellent sensory characteristics (no burping).
These efforts result in a fish oil considered “#1 in Freshness”.
A common way used by the omega-3 industry assesses freshness is the Total Oxidation (TOTOX) marker. TOTOX is a measure of both primary and secondary oil oxidation.
The rigid standard for TOTOX set by GOED is no more than 26.0, But the AlaskOmega® limit is just 5.0. And actually, AlaskOmega® values typically range from 0 to 3, reflecting its market-leading position for oil freshness.
A second indicator of freshness in Peroxide Value (PV). Once again AlaskOmega® standards are much high than GOED industry standards. Whereas GOED has a maximum PV value of 5.0, the maximum value for the AlaskOmega® fish oil in TrueOmega-3™ is 80% lower, or 1.0.
To reduce oxidation risk further, we protect your fish oil by buffering it with powerful antioxidants. These are natural forms of vitamin E from sunflower oil called “mixed tocopherols.”
Together these antioxidants have been shown to prevent the oxidation of fish oil and keep it fresh for its entire shelf life. And that’s why they are in TrueOmega-3™.
Dietary Supplement / 60 Soft Gels
Serving Size: 2 softgels
Servings per Container: 30
|Amount Per Serving||% Daily Value|
|Calories from Fat||11|
|Fish Oil||1300 mg||**|
|Omega-3 Fatty Acids:|
|EPA (eicosapentaenoic acid)||468mg||**|
|DHA (docosahexaenoic acid)||350mg||**|
|Mixed Tocopherols||3 mg||**|
* Percent Daily Values Are Based on a 2000 Calorie Diet
** Daily Value not established.
Other Ingredients: Gelatin, glycerin, purified water, sunflower oil and turmeric.
AlaskOmega is a registered trademark of Organic Technologies.
Suggested Use: Take two (2) soft gels once or twice daily with meals or as directed by your health care practitioner.
Fish oil sustainably sourced from wild Alaskan Pollock, purified beyond industry standards and considered #1 in "freshness".
A total of 818mg per serving (2 soft gels) of EPA and DHA, the omega-3 fatty acids recommended for consumption by medical scientists and authorities.
Natural vitamin E in the form of mixed tocopherols and a turmeric coating to protect the fish oil from oxidation damage.
All in easy to swallow soft gels!
Keep out of reach of children
Store in a cool dry place
Do not use if seal is broken or missing
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Assembled in the USA
- BPA Free
- Gluten Free
Manufactured for and Distributed by: NatureCity®
Boca Raton, FL 33487 www.naturecity.com
To re-order call toll free 1-800-593-2563
Szu-Yun Wu, Jordi Mayneris-Perxachs, Julie A Lovegrove, Susan Todd, and Parveen Yaqoob. “Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype.” American Journal of Clinical Nutrition. November, 2014 100: 1232-1243.
Kuan-Pin Su, Hsueh-Chou Lai, Hui-Ting Yang, Wen-Pang Su, Cheng-Yuan Peng, Jane Pei-Chen Chang, Hui-Chih Chang, Carmine M. Pariante. “Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial.” Biological Psychiatry. October 1, 2014, Volume 76, Issue 7, Pages 559–566.
A.Z. Naqvi, H. Hasturk, L. Mu, R.S. Phillips, R.B. Davis, S. Halem, H. Campos, J.M. Goodson, T.E. Van Dyke, and K.J. Mukamal. “Docosahexaenoic Acid and Periodontitis in Adults: A Randomized Controlled Trial.” Journal of Dental Research. August 2014; vol. 93, 8: pp. 767-773.
Daiello LA, Gongvatana A, Dunsiger S, Cohen RA, Ott BR. “Association of fish oil supplement use with preservation of brain volume and cognitive function.” Alzheimer’s & Dementia. 2014 Jun 18. pii: S1552-5260(14)00079-X.
Wang X, Zhu M, Hjorth E, Cortés-Toro V, Eyjolfsdottir H, Graff C, Nennesmo I, Palmblad J. “Resolution of inflammation is altered in Alzheimer's disease.” Alzheimer’s & Dementia. February, 2014, Vol. 11, Issue 1, p40–50.e2.
Virtanen J, Siscovick D, Lemaitre R, Longstreth W, Spiegelman D, Rimm E, King I, Mozaffarian D. “Circulating Omega-3 Polyunsaturated Fatty Acids and Subclinical Brain Abnormalities on MRI in Older Adults: The Cardiovascular Health Study.” Journal of the American Heart Association. October, 2013;2:e000305.
Sheppard J, Singh R, McClellan A, Weikert M, Scoper S, Joly T, Whitley W, Kakkar E, Pflugfelder S. “Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial.” Cornea. October 2013, Volume 32, Issue 10, Pages 1297-1304.
Pirillo A, Catapano A. “Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia.” International Journal of Cardiology. July, 2013. Vol. 170, Issue 2, S16–S20.
Sauder KSkulas-Ray A, Campbell T, Johnson J, Kris-Etherton P, West S. “Effects of Omega-3 Fatty Acid Supplementation on Heart Rate Variability at Rest and During Acute Stress in Adults With Moderate Hypertriglyceridemia.” Psychosomatic Medicine. 2013 May; 75(4): 382–389.
Wong A, Chan D, Barrett P, Adams L, Watts G. “Supplementation with n3 Fatty Acid Ethyl Esters Increases Large and Small Artery Elasticity in Obese Adults on a Weight Loss Diet.” The Journal of Nutrition. April, 2013 143: 437-441.
Orchard T, Ing S, Lu B, Belury M, Johnson K, Wactawski-Wende J, Jackson R. “The association of red blood cell n-3 and n-6 fatty acids with bone mineral density and hip fracture risk in the women's health initiative.” Journal of Bone and Mineral Research. March 2013, Volume 28, Issue 3, pages 505–515.
Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R. “Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial.” Brain, Behavior, and Immunity. 2012 Aug;26(6):988-95.
Gabbay V, Babb J, Klein R, Panzer A, Katz Y, Alonso C, Petkova E, Wang J, Coffey B. “A Double-Blind, Placebo-Controlled Trial of Omega-3 Fatty Acids in Tourette’s Disorder.” Pediatrics. 2012 Jun; 129(6): e1493–e1500.
Lok C, Moist L, Hemmelgarn B, Tonelli M, Vazquez M, Dorval M, Oliver M, Donnelly S, Allon M, Stanley K. “Effect of Fish Oil Supplementation on Graft Patency and Cardiovascular Events Among Patients With New Synthetic Arteriovenous Hemodialysis Grafts.” The Journal of the American Medical Association. May, 2012;307 (17): 1809-1816.
Meldrum SJ, D'Vaz N, Dunstan J, Mori TA, Prescott SL. “Infant Fish Oil Supplementation Study: Design & research protocol of a double-blind, randomised controlled n--3 LCPUFA intervention trial in term infants.” Contemporary Clinical Trials. September, 2011 (32): 771- 778.
Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC. “Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer.” Cancer. 2011 Aug 15;117(16):3774-80.
Dangour A, Allen E, Elbourne D, Fasey N, Fletcher A, Hardy P, Holder G, Knight R, Letley L, Richards M, Uauy R. “Effect of 2-y n−3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial.” American Journal of Clinical Nutrition. 2010. May.
Montegaard C, Tulk HM, Lauritzen L, Tholstrup T, Robinson LE. “Acute ingestion of long-chain (n-3) polyunsaturated fatty acids decreases fibrinolysis in men with metabolic syndrome.” Journal of Nutrition. 2010 Jan;140(1):38-43.
Metherel AH, Armstrong JM, Patterson AC, Stark KD. “Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women.” Prostaglandins, Leukotrienes and Essential Fatty Acids. 2009 Jul;81(1):23-9.
Eslick GD, Howe PR, Smith C, Priest R, Bensoussan A. “Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis.” International Journal of Cardiology. 2009 Jul 24;136(1):4-16.
Hanwell HE, Kay CD, Lampe JW, Holub BJ, Duncan AM. “Acute fish oil and soy isoflavone supplementation increase postprandial serum (n-3) polyunsaturated fatty acids and isoflavones but do not affect triacylglycerols or biomarkers of oxidative stress in overweight and obese hypertriglyceridemic men.” Journal of Nutrition. 2009 Jun;139(6):1128-34.
Kitson A, Patterson A, Izadi H, Stark K. “Pan-frying salmon in an eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) enriched margarine prevents EPA and DHA loss.” Food Chemistry. Volume 114, Issue 3, 1 June 2009, Pages 927–932.
Barrow C, Nolan C, Holub B. “Bioequivalence of encapsulated and microencapsulated fish oil supplementation. “ Journal of Functional Foods. January, 2009. 1:38-43.
Martin L, Zarn D, Hansen AM, Wismer W, Mazurak V. “Food products as vehicles for n-3 fatty acid supplementation.” Canadian Journal of Dietetic Practice and Research. 2008 Winter;69(4):203-7.
Caslake MJ, Miles EA, Kofler BM, Lietz G, Curtis P, Armah CK, Kimber AC, Grew JP, Farrell L, Stannard J, Napper FL, Sala-Vila A, West AL, Mathers JC, Packard C, Williams CM, Calder PC, Minihane AM. “Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study.” American Journal of Clinical Nutrition. 2008 Sep;88(3):618-29.
Caron-Dorval D, Paquet P, Paradis AM, Rudkowska I, Lemieux S, Couture P, Vohl MC. “Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids.” Journal of Nutrigenetics and Nutrigenomics. June, 2008;1(4):205-12.
Armah CK, Jackson KG, Doman I, James L, Cheghani F, Minihane AM. “Fish oil fatty acids improve postprandial vascular reactivity in healthy men.” Clinical Science. 2008 Jun;114(11):679-86.
Vega GL, Chandalia M, Szczepaniak LS, Grundy SM. “Effects of N-3 fatty acids on hepatic triglyceride content in humans.” Journal of Investigative Medicine. 2008 Jun;56(5):780-5.
Vaisman N, Kaysar N, Zaruk-Adasha Y, Pelled D, Brichon G, Zwingelstein G, Bodennec J. “Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids.” American Journal of Clinical Nutrition. 2008 May;87(5):1170-80.
Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN. “Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.” Nephrology Dialysis Transplantation. 2007 Dec;22(12):3561-7.
Goldberg RJ, Katz J. “A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.” Pain. 2007 May;129(1-2):210-23.
Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. “Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.” American Journal of Psychiatry. 2006 Jun;163(6):1098-100.
Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. “Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects.” European Journal of Clinical Investigation. 2005 Nov;35(11):691-9.
Bouzan C, Cohen JT, Connor WE, Kris-Etherton PM, Gray GM, König A, Lawrence RS, Savitz DA, Teutsch SM. “A quantitative analysis of fish consumption and stroke risk.” American Journal of Preventive Medicine. 2005 Nov;29(4):347-52.
Bruce WR1, Cirocco M, Giacca A, Kim YI, Marcon N, Minkin S. “A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation.” British Journal of Cancer. 2005 Sep 19;93(6):639-46.
Young G, Conquer J, Thomas R. “Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder” Reproduction, Nutrition, Development. January, 2005, 45 (5), pp.549-558.
Buckley R, Shewring B, Turner R, Yaqoob P, Minihane A. “Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.” British Journal of Nutrition. (2004, Sept), 92, 477–483.
Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM. “Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.” Circulation. 2004 Sep 21;110(12):1645-9.
Mesa MD, Buckley R, Minihane AM, Yaqoob P. “Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on the oxidizability and thrombogenicity of low-density lipoprotein.” Atherosclerosis. 2004 Aug;175(2):333-43.
Kew S, Mesa M, Tricon S, Buckley R, Minihane A, Yaqoob P. “Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans.” American Journal of Clinical Nutrition. April, 2004;79:674-81.
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. “Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial.” Journal of Allergy and Clinical Immunology. 2003 Dec;112(6):1178-84.
Stark K, Mulvad G, Pedersen H, Dewailly E. “Fatty acid compositions of serum phospholipids of postmenopausal women: a comparison between Greenland Inuit and Canadians before and after supplementation with fish oil.” Nutrition. July, 2002;18:627-30.
Stark K, Park E, Maines V, Holub B. “Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial.” American Journal of Clinical Nutrition. August, 2000;72:389-94.
*The views and opinions expressed by contributors and or product reviews are their own and not
necessarily those of NatureCity. These reviews should not be taken as recommendations but rather
client opinions of the products that they have used.